Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒ ‒ FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million ‒ ‒ Expects Q4 Adjusted EBITDA of Between $77 million and $81 ...
PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare ...
According to MarketsandMarkets, the ANZ Fleet Management Market is projected to grow from USD 0.76 billion in 2025 and to reach USD 1.76 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback